Company intelligence / Profile preview

Aikangwei

Shenzhen, Guangdong Province, China

Ownership: Private
Development stage: Commercial

Overview

Aikang MedTech develops and commercializes a broad portfolio of in vitro diagnostic instruments and reagents, with mature product lines covering chemiluminescence, immunofluorescence, ELISA, and microcolumn gel technologies for clinical laboratory use.

Therapeutic areas: OncologyWomen's HealthEndocrinologyHematologyCardiovascularInfectious Diseases
Modalities: ChemiluminescenceImmunofluorescenceELISAMicrocolumn gel technology
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Aikangwei.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aikangwei.

Explore the full profile